We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Pfizer Healthcare Ireland

9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24,
Telephone: +353 1 467 6500
Fax: +353 1 467 6501
Medical Information Direct Line: 1 800 633 363
Medical Information Website: http://www.pfizermedicalinformation.ie
Patient Information Leaflet last updated on medicines.ie: 16/01/2018
PIL Dalacin C Phosphate 150mg/ml Concentrate for Solution for infusion or Solution for Injection,

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 16/01/2018 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - contraindications
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals
Updated on 11/01/2018 and displayed until 16/01/2018
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals
Updated on 11/04/2017 and displayed until 11/01/2018
Reasons for adding or updating:
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals
Updated on 28/02/2017 and displayed until 11/04/2017
Reasons for adding or updating:
  • Change to Section 1 - what the product is
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 2 - excipient warnings
  • Change to section 3 - dose and frequency
  • Change to section 4 - possible side effects
  • Change to section 5 - how to store or dispose
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals
Updated on 17/05/2016 and displayed until 28/02/2017
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to instructions about missed dose
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to how the medicine works
  • Change to date of revision
  • Change to dosage and administration
Updated on 14/11/2014 and displayed until 17/05/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 07/07/2014 and displayed until 14/11/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 27/05/2014 and displayed until 07/07/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 12/12/2013 and displayed until 27/05/2014
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 08/11/2012 and displayed until 12/12/2013
Reasons for adding or updating:
  • Change of licence holder
  • Change to marketing authorisation holder
Updated on 03/07/2012 and displayed until 08/11/2012
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 08/06/2012 and displayed until 03/07/2012
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 18/05/2012 and displayed until 08/06/2012
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to date of revision
Updated on 20/10/2011 and displayed until 18/05/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to marketing authorisation holder
Updated on 07/10/2011 and displayed until 20/10/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 13/08/2009 and displayed until 07/10/2011
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 13/05/2009 and displayed until 13/08/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 30/01/2008 and displayed until 13/05/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to storage instructions
  • Change to side-effects
  • Change to date of revision
Updated on 07/12/2006 and displayed until 30/01/2008
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Clindamycin Phosphate